01 1Ako Kasei Co., Ltd.
02 1Macco Organiques, s. r. o.
03 1Tomita Pharmaceutical Co., Ltd.
01 1Calcium chloride hydrate
02 1Calcium chloride, "Tomita"
03 1Japanese Pharmacopoeia calcium chloride hydrate
01 1Czech Republic
02 2Japan
Japanese Pharmacopoeia Calcium Chloride Hydrate
Registration Number : 229MF10097
Registrant's Address : 329 Sakae, Ako City, Hyogo Prefecture
Initial Date of Registration : 2017-05-16
Latest Date of Registration : 2017-05-16
Registration Number : 223MF10151
Registrant's Address : Zahradni(') 46c,792 01 Brunta(')l, Czech Republic
Initial Date of Registration : 2011-10-14
Latest Date of Registration : 2020-12-18
Registration Number : 217MF10519
Registrant's Address : 85-1 Maruyama, Myojin, Setocho, Naruto City, Tokushima Prefecture
Initial Date of Registration : 2005-09-07
Latest Date of Registration : 2006-12-27
22
PharmaCompass offers a list of Calcium Chloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Calcium Chloride manufacturer or Calcium Chloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Chloride manufacturer or Calcium Chloride supplier.
PharmaCompass also assists you with knowing the Calcium Chloride API Price utilized in the formulation of products. Calcium Chloride API Price is not always fixed or binding as the Calcium Chloride Price is obtained through a variety of data sources. The Calcium Chloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1, including repackagers and relabelers. The FDA regulates CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 supplier is an individual or a company that provides CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 active pharmaceutical ingredient (API) or CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 finished formulations upon request. The CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 suppliers may include CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 API manufacturers, exporters, distributors and traders.
click here to find a list of CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 Drug Master File in Japan (CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 JDMF) empowers CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 JDMF during the approval evaluation for pharmaceutical products. At the time of CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1 suppliers with JDMF on PharmaCompass.
We have 3 companies offering CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER-1
Get in contact with the supplier of your choice:
